Mindray (MR) Enters Oversold Territory - Tale of the Tape


Shutterstock photo

Mindray Medical International Ltd's ( MR ) share price has entered into oversold territory with an RSI value of 28.7. The Zacks Consensus Estimate for Mindray for the full year period has improved 2 cents over the past two months to $2.14 per share. Currently, Mindray has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on ( MR ) after its recent drop.

MINDRAY MEDICAL (MR): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks

More from Zacks.com




Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com